Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 13, 2026

America Is Closing the Gap in the Rare Earth Supply Chain Race - OilPrice.com Market Commentary

View original at finance.yahoo.com
America Is Closing the Gap in the Rare Earth Supply Chain Race - OilPrice.com Market Commentary NEW YORK, March 13, 2026 /PRNewswire/ -- Access to rare earths has become a central challenge for advanced defense systems, high-performance manufacturing, and next-generation energy technologies…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • IperionX has achieved significant EBITDA inflection point in early 2026

    60% confidence
  • REalloys is already operating in the most strategic segment of rare earth supply chain, converting heavy rare earth materials into high-performance magnets and alloys inside the United States

    60% confidence
  • No other supplier in North America is currently producing the same grade of qualified heavy rare earth metals and alloys

    60% confidence
  • Heavy rare earth production from the expanded SRC facility is on track to come online in early 2027

    60% confidence
  • Oyu Tolgoi is expected to become one of the largest new sources of copper globally

    60% confidence
  • For Washington, the challenge is not geology — it's processing

    60% confidence
  • Rare earth metallization and alloying is the weakest and hardest-to-restore link in any non-Chinese supply chain

    60% confidence
  • Initial production from expanded SRC facility is expected early next year

    60% confidence
  • REalloys is already delivering qualified materials under Department of Defense contracts

    60% confidence
  • Metal and alloy production represents an experience-based bottleneck that resists shortcuts, even when capital is abundant

    60% confidence
  • Expansion would make REalloys the sole commercial-scale North American source of dysprosium and terbium oxides

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com